WAX.ASX
Wam Research Ltd
https://www.marketindex.com.au/asx/wax/financials
Annual Financial Summary
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
Profitability
NPAT ($)
32,471,074
16,854,237
NPAT Margin
138,268.92%
--
Abnormals ($)
-
-
NPAT before Abnormals ($)
32,471,074
16,854,237
Return on Equity (ROE)
15.13%
8.46%
Return on Assets (ROA)
13.90%
8.28%
Valuation
PE Ratio
6.70
12.54
PE Relative to Market
47.9%
104.7%
Price to Book
1.02
1.07
Price to Cash Flow
7.11
13.77
Shares Outstanding (M)
204.07
200.89
Market Cap ($M)
$219.37
$212.94
Enterprise Value ($M)
$207.59
$201.73
Performance
Total Shareholder Return
11.3%
-11.3%
Relative to Market
-1.2%
-26.1%
Per Share
Earnings (EPS Adjusted)
16.04
8.45
Earnings (with Abnormals)
16.04
8.45
Cash Flow
8.50
(5.10)
Cash
0.06
0.06
Net Tangible Assets
1.05
0.99
Book Value
1.05
0.99
Share Price
$1.07
$1.06
Liquidity
Quick Ratio
13.09
42.60
Current Ratio
13.09
42.60
Efficiency
Asset Turnover
0.00
0.00
Inventory Turnover
-
-
Working Capital Turnover
0.00
0.00
Dividends
DPS (c)
10.00
10.00
Dividend yield
9.30%
9.43%
Franking
60%
80%
Gross DPS (c)
12.57
13.43
Gross Dividend Yield
11.69%
12.67%
Payout Ratio
62%
118%
Member Content
Source:
Annual Financial Income Statement
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
Revenue from Operations
Investment Income
54,220,911
25,789,384
Other Income
46,968
-
Expenses
(9,370,184)
(3,143,465)
Profit / Loss before income tax
44,897,695
22,645,919
Tax Expense
(12,426,621)
(5,791,682)
NPAT before Abnormals
32,471,074
16,854,237
Abnormals
-
-
Abnormals Tax
-
-
Net Abnormals
-
-
Outside Equity
-
-
Preference Dividends
-
-
Reported NPAT after Abnormals
32,471,074
16,854,237
EQUITY
Share End
204,069,123
200,885,140
Share Weighted
202,480,676
199,360,594
Ordinary Dividends
(20,330,062)
(20,015,846)
EPS Adjusted
160,400
84,500
EPS after Abs
160,366
84,541
Equity Profit / Loss
-
-
Member Content
Source:
Annual Financial Balance Sheet
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
CURRENT ASSETS
Cash and Cash Equivalents
11.78
11.21
Receivables
3.51
4.72
Investments
205.9
172.61
Other Current Assets
-
-
Total Current Assets
221.2
188.54
NON-CURRENT ASSETS
Investments
1.26
1.43
Property
-
-
Other Non-Current Assets
11.18
13.59
Total Non-Current Assets
12.44
15.02
TOTAL ASSETS
233.64
203.56
CURRENT LIABILITIES
Creditors
10.43
2.75
Provisions
6.47
1.68
Other Liabilities
-
-
TOTAL CURRENT LIABILITIES
16.9
4.43
NON-CURRENT LIABILITIES
Borrowings
-
-
Deferred Tax
2.08
-
Other Non-Current Liabilities
-
-
TOTAL NON-CURRENT LIABILITIES
2.08
-
TOTAL LIABILITIES
18.97
4.43
NET ASSETS
252.61
207.99
Total Equity Attr. to Holders
214.66
199.14
Outside Equity
-
-
TOTAL EQUITY
214.66
199.14
Member Content
Source:
Annual Financial Cash Flow
Printable Version
06/2024
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
449.31
432.64
Payments
(432.7)
(444.47)
Funds from Operations
-
-
Dividends Received
4.1
5.23
Interest Received
0.81
0.55
Interest Paid
-
-
Tax Paid
(3.1)
(3.07)
Other Operating Cash
(1.16)
(1.02)
NET CASH FROM OPERATING ACTIVITIES
17.27
(10.13)
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
Payments
-
-
PP&E
-
-
Proceeds PP&E
-
-
Purchase Subsidiary
-
-
Proceeds Subsidiary
-
-
Loans Granted
-
-
Loans Repaid
-
-
Other Investing Cash
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
-
-
Proceeds from Borrowings
-
-
Borrowings
-
-
Dividends Paid
(16.7)
(16.29)
Other Financing Cash
-
-
NET CASH FROM FINANCING ACTIVITIES
(16.7)
(16.29)
NET CHANGE IN CASH
0.57
(26.42)
CASH AT START
11.21
37.63
Exchange Rate Adjustment
-
-
Other Cash Adjustment
-
-
CASH AT END
11.78
11.21
Member Content
Source: